1. Vertex Pharma Strikes Deal with Halozyme for Hypercon Drug Delivery Technology
Vertex Pharmaceuticals has entered a strategic collaboration and licensing agreement with Halozyme Therapeutics, securing access to Halozyme's proprietary ENHANZE® drug delivery technology. The deal centers on Halozyme's Hypercon™ platform, a subcutaneous delivery system designed to enable the rapid administration of l...